Reaching this board takes an FDA-approved product with a published price beside it, which is a far higher bar than selling a compounded version of the same compound.
This board is narrow on purpose, and a short list is the finding rather than a gap. Selling a compounded GLP-1 needs a prescriber and a compounding pharmacy. Listing a brand-name product means sourcing an approved drug and printing what it costs. Fewer telehealth platforms clear the second bar, so a reader should expect a shorter list here than on the compounded boards.
The distinction underneath it is the one that matters most in this whole category. A brand-name GLP-1 is an FDA-approved finished drug product with a manufacturer standing behind it. A compounded version is prepared by a compounding pharmacy and has not been through that approval. The prices are far apart because they are set by different things: a manufacturer's list price on one side, a pharmacy's own ingredients and labor on the other.
A short board is still a usable one. If a listed option does not fit, a brand-name prescription can also be filled outside a telehealth platform entirely, through a prescriber and a pharmacy of the patient's choosing. The value of this board is that it shows which platforms will name a price for the approved product at all, which is a disclosure most of the category does not offer.
Quick picks
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
Quick picks: top providers for brand-name, by score
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A large telehealth weight-loss platform offering one flat price for either compounded semaglutide or tirzepatide, plus separate access to brand-name GLP-1s such as Wegovy, Ozempic, Zepbound, and Mounjaro at their own listed prices.
Best for: comparing a flat compounded price against brand-name GLP-1 options in one place
$650/mostarting at, per month
Strengths
One flat program price covers either semaglutide or tirzepatide, so tirzepatide does not carry the higher price it often does elsewhere
Also offers brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro) for readers who want an FDA-approved product instead of a compounded one
Displays a LegitScript seal and holds BBB accreditation
Worth knowing
The lowest advertised price requires a 12-month prepaid commitment; paying month to month costs about $120 more per month
Describes its compounding pharmacies only as ‘503A-licensed,’ without naming which pharmacy fills a given order
Its own pricing pages are not fully consistent with each other — one page lists Wegovy starting near $199/month while the homepage carousel advertises $650/month and up
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A nationwide telehealth platform that prints its introductory rate, its standing rate and its brand-name cash prices on a single page, and states that no membership or additional fee sits on top of the medication figure.
Best for: readers who want the introductory rate and the standing rate published together before they commit
$1498/moper month, as listed
Strengths
Prints the introductory rate and the rate that follows it side by side, which is the disclosure most sellers in this comparison leave to a footnote
States that no membership fee or additional charge sits on top of the medication price
Publishes cash figures for brand-name Zepbound and Wegovy on the same page as the compounded rates
Worth knowing
The compounding pharmacy is described by licensing class and standards rather than named
The starter and transfer rates are limited to new customers, so a returning patient pays the standing rate from the first fill
The starter program is tied to the lowest available dose, which is not where most patients stay
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A telehealth platform built around getting brand-name GLP-1s covered by insurance, with a cash-pay compounded semaglutide option behind it for patients whose coverage does not come through.
Best for: patients with insurance who want help getting a brand-name GLP-1 covered rather than paying cash for a compounded one
$25/moas low as, per month, and only once insurance coverage has been secured
Strengths
The only provider in this comparison whose main route is brand-name medication through insurance rather than cash-pay compounded medication
Publishes both an insured figure and a cash-pay figure, so the two paths can be compared before starting
Coordinators work the coverage process on the patient side rather than leaving prior authorization to the patient
Worth knowing
The headline figure applies only once insurance coverage has actually been secured. A reader whose plan declines coverage is looking at the cash-pay figure instead, and the difference is very large
The cash-pay rate is itself conditional on buying a quarter at a time
The operating entity received an FDA warning letter (No. 717987, issued February 2026) about false or misleading claims for compounded semaglutide and tirzepatide on a different website it ran. It concerns how products were promoted, not what was in a vial
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A large telehealth weight-loss platform that prices medication by dose rather than at a flat rate, bills a separate monthly membership, and carries an unusually wide catalog including an oral semaglutide pill and a brand-name option.
Best for: readers who want the lowest medication figure in this comparison and will do the two-part arithmetic
$299/moas low as, per month for medication; membership billed separately
Strengths
The lowest compounded figures in this comparison, and Mochi explains plainly that the price moves with the dose rather than burying it
Offers an oral semaglutide pill as well as the weekly injection, at a figure close to the injection
Lists a brand-name tirzepatide option at a cash figure far below the usual brand-name rate
Worth knowing
Every medication figure is a lowest-dose starting price with a separate membership on top, so the advertised number is the floor of two costs rather than the bill
The compounding pharmacy is not named, and the site states that pricing varies by pharmacy without saying which one fills an order
No list of served states appears on its weight-loss, pricing or FAQ pages, and the site notes that promotional pricing is not available in all states
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A telehealth platform selling compounded semaglutide and tirzepatide at a low medication rate that sits on top of a separately billed membership, alongside brand-name Ozempic, Wegovy, Zepbound and Mounjaro at their own published cash rates.
Best for: comparing a compounded rate against four brand-name cash prices on one page
$1399/moper month for medication only; a separate Eden membership is required
Strengths
Publishes a compounded price and a brand-name price for both semaglutide and tirzepatide on the same page, so the two routes can be compared without a second intake
The membership cost is printed in the same footnote as the medication price rather than appearing later at checkout
States that the medication price holds as the dose is adjusted through the program
Worth knowing
Every advertised figure is medication only. A membership is required, and it renews at a higher rate after the first month, so the real first-year cost is two numbers rather than one
The compounding pharmacy that fills an order is not named
The line about pharmacies licensed in all 50 states describes the pharmacies Eden works with, not the states Eden serves; no list of served states appears on its GLP-1 page or in its terms
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A telehealth weight-loss platform selling a compounded GLP-1 injection and a compounded GLP-1 tablet at published starting figures, with brand-name Ozempic offered alongside them at a cash rate.
Best for: readers comparing a compounded tablet against a compounded injection at published starting figures
$1999/mostarting at, per month
Strengths
Offers a compounded tablet as well as a weekly injection, and prices both on the same page
Publishes a cash figure for brand-name Ozempic rather than routing the question into an intake
The operating entity, its address and the clinical groups behind the prescriptions are all named in the terms
Worth knowing
Both compounded figures are labelled only as GLP-1, so a reader cannot tell whether a price is for semaglutide or tirzepatide before starting an intake
The compounding pharmacies are described as multiple certified partners and are not named
The FAQ section repeats one answer about serving multiple states under every question, including the question about cost, so several basic answers are not actually published
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
Every provider on this page earns one point for each of the four items below that it satisfies, out of a possible four. That count is scaled to a score out of 10 — two of four satisfied is a 5.0, for example. The score never factors in an FDA warning letter: a letter discloses, it does not disqualify.
Names its compounding pharmacy. The provider publishes the name of the pharmacy that compounds and fills the prescription, not only a general licensing claim.
Publishes its price. A reader can find a real monthly figure on the provider’s own site before starting an intake, with its billing cycle or plan term stated.
Ships to all 50 states. The provider is licensed to prescribe and ship in every state, not a subset.
Offers a brand-name option. The provider also lists an FDA-approved brand-name GLP-1 (such as Wegovy, Ozempic, Zepbound, or Mounjaro), not only a compounded product.
Every rubric item above is a fact declared from research, checked against the provider’s own site — never a word count or a keyword match run over review text. Prices are re-verified on the date printed next to each figure and always carry their billing cycle or plan term. Ranking position never depends on which providers pay a commission: none of the 16 providers reviewed on this site is a paid partner today (see the disclosure above), and the same rule holds if that changes.
A provider qualifies for this board by listing a brand-name, FDA-approved GLP-1 and publishing a price for it. Mentioning a brand in marketing copy is not enough, and neither is a compounded product described with a brand name attached. Sellers offering only compounded medication are ranked on the other boards, where their pricing can be compared against comparable products. When only one provider meets the bar, the board shows one provider, because a list padded with near-misses would be worth less than a short accurate one.
How to use this board
Confirm which specific approved product a platform lists, since a brand-name option is product by product rather than a blanket offering.
Read the price qualifier: a listed figure is a cash price and answers no question about what a plan would pay.
Check the verification date, then confirm the current figure on the platform's own pricing page.
If the board is short, use it as a starting point and compare against a prescription filled through a pharmacy directly.
Things to watch for
A page can lean on a brand name while dispensing a compounded vial. The brand name describes the ingredient in that copy, not the product in the box, so confirm what checkout actually ships.
A published brand-name figure is a cash price. It is not a copay, not a negotiated rate, and it says nothing about what any plan would charge for the same product.
Listing an approved product is not a promise of supply. A listing is not a guarantee that a prescriber will write it, that a pharmacy has it in stock, or that it arrives quickly.
A platform's own pages can disagree about the same brand product, with one figure on a pricing page and a different one in homepage marketing. Take the pricing page as the claim to check, then confirm it before paying.
Frequently asked questions
What is the difference between a brand-name and a compounded GLP-1?
A brand-name GLP-1 is an FDA-approved finished drug product made by a manufacturer to a fixed formulation. A compounded version is prepared by a compounding pharmacy and has not gone through that approval process. Compounded products can also vary between pharmacies, including in what else is mixed into the same vial.
Why is the brand-name price so much higher?
The two figures are set by completely different mechanisms. A manufacturer sets a list price for an approved product, and a platform's cash price sits somewhere above or below it depending on the deal it has. A compounding pharmacy prices its own ingredients and labor instead. Neither figure is a discount on the other.
What keeps a provider off this board?
The bar is specific. A platform has to list a brand-name, FDA-approved GLP-1 and publish a price for it before it can be compared here. A telehealth program built entirely around compounded medication does not qualify, and those sellers are ranked on the boards where a like-for-like comparison is possible.
Can I use a brand-name option through insurance here?
That is a question for the plan rather than for the platform. A price listed on a telehealth site is a cash figure, and it is calculated without reference to anyone's benefits. Ask the plan about the specific named product, get its answer, and only then compare that answer against a published cash figure.
Is a brand-name product the better choice?
That decision belongs to a patient and their prescriber, not to a comparison table. What a board can honestly say is what differs on paper. One product has been through FDA approval as a finished drug and the other has not, and the two are priced by unrelated mechanisms.
Found leads this board today. Its full price, with its qualifier, is above — visiting a provider’s site does not commit you to anything.
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
